Justification for Disease-specific Data

161 new data elements that were not included in the previously reviewed ICR or approved through nonsubstantive change requests were added for 8 conditions: 4 new disease-specific data elements for
Brucellosis, 2 new disease-specific data elements for Candida auris, 21 new disease-specific data
elements for Carbapenemase-Producing Organisms (CPO), 1 new disease-specific data element for
Carbon Monoxide Poisoning, 1 new disease-specific data element for Hepatitis, 7 new disease-specific
data elements for Leptospirosis, 21 new disease-specific data elements for Melioidosis, and 104 new
disease-specific data elements for Viral Hemorrhagic Fevers. Names, descriptions, value set codes (the
answer list for coded data elements from CDC vocabulary server (PHIN VADS) which can be accessed
at http://phinvads.cdc.gov), and justification for the addition of these new data elements are below:

Brucellosis
The impetus/urgency for
CDC to add data elements
for this condition

•
•
•
•

To make surveillance more comprehensive and informative for
public health actions related to travel
To provide more information about risk factors associated with
traveling
To harmonize collection of travel-related information amongst
Message Mapping Guides (MMGs) and facilitate future
jurisdiction implementation
To help monitor epidemiology
Value Set Code

Data Element Name
Travel Outside USA
Prior to Illness Onset
within Program Specific
Timeframe
Did the Case Travel
Domestically Prior to
Illness Onset

Data Element Description
Did the subject travel
PHVS_YesNoUnknown_CDC
internationally in the six
months prior to illness onset?
Did the subject travel
PHVS_YesNoUnknown_CDC
domestically in the six
months prior to illness onset?

If the travel exposure
window used by the
Specify Different Travel jurisdiction is different from
Exposure Window
that stated in the travel
exposure questions, specify
the time interval in days
here. Otherwise, leave blank.
Date of Arrival to Travel Date of Arrival to Travel
Destination
Destination

1

R=Required; 1=Priority 1, 2=Priority 2, 3=Priority 3

1

CDC
Priority1
1

2

N/A

3

N/A

3

Candida auris
The impetus/urgency for
CDC to add data elements
for this condition

•
•

•
•
Data Element
Name
Date Arrived at
Healthcare
Facility
Date Departed
Healthcare
Facility

Value Set Code
Data Element Description
Start date of visit/admission

N/A

CDC
Priority1
2

End date of visit/admission

N/A

2

CarbapenemaseProducing Organisms
(CPO)
The impetus/urgency for
CDC to add data elements
for this condition

Data Element
Name
State lab isolate
id
County of
facility
State of facility
Travel Outside
USA Prior to
Illness Onset
within Program
Specific
Timeframe
International
Destination(s)

To make surveillance more comprehensive and informative for
public health actions
To provide more information about risk factors (related cases and
conditions, high acuity care needs, healthcare facility exposure,
travel, and specimen testing) that have been associated with
colonization or infection
To monitor epidemiology
To update guidance on infection control and prevention

•

To make surveillance more comprehensive and informative for
public health actions
• To provide more information about risk factors (related cases and
conditions, high acuity care needs, healthcare facility exposure,
travel, and specimen testing) that have been associated with
colonization or infection
• To monitor epidemiology
• To update guidance on infection control and prevention
Value Set Code
CDC
Priority1
Data Element Description
Lab isolate identifier from
N/A
1
public health lab
County of facility where
PHVS_County_FIPS_6-4
1
specimen was collected
State of facility where
PHVS_State_FIPS_5-2
1
specimen was collected
Did the patient travel
PHVS_YesNoUnknown_CDC
2
internationally in the year
prior to the date of specimen
collection?

Names of the country(ies)
outside of the United States

PHVS_Country_ISO_3166-1
2

2

of Recent
Travel

Healthcare
Outside USA

Country(ies) of
Healthcare
Outside USA

Gene Identifier
Previously
Counted Case
Previously
Reported State
Case Number

WGS ID
Number
Tracheostomy
Tube at
Specimen
Collection
Ventilator Use
at Specimen
Collection
Long-term Care
Resident

Type of Longterm Care
Facility

the patient traveled to in the
year prior to the date of
specimen collection, if the
patient has traveled outside
of the United States during
that time.
Patient received healthcare
PHVS_YesNoUnknown_CDC
outside of the United States
in the year prior to the date
of specimen collection.
Names of the country(ies)
PHVS_Country_ISO_3166-1
outside of the United States
where the patient received
healthcare in the year prior to
the date of specimen
collection, if the patient
traveled outside of the
United States during that
time.
Gene identifier
TBD
Was patient previously
counted as a
colonization/screening case?
If patient was previously
counted as
colonization/screening case
please provide related case
ID(s)
Genomic sequencing ID
number
Did patient have a
tracheostomy tube at the
time of specimen collection?

2

2

1

PHVS_YesNoUnknown_CDC

1

N/A

1

N/A

2

PHVS_YesNoUnknown_CDC

2

Was patient on a ventilator at PHVS_YesNoUnknown_CDC
the time of specimen
collection?
Did the patient have a stay in PHVS_YesNoUnknown_CDC
a long-term care facility in
the 90 days before specimen
collection date?
If patient had a stay in a
TBD
long-term care facility in the
90 days before specimen
collection date, indicate the
type of long-term care
facility.

2

3

2

2

Healthcare
Outside
Resident State

Indicate if the patient
PHVS_YesNoUnknown_CDC
received overnight
healthcare within the United
States, but outside of the
patient's resident state in the
year prior to the date of
specimen collection.
Type of
Indicate the physical location TBD
Location Where type of the patient when the
Specimen
specimen was collected
Collected
Infection with
Does the patient have
PHVS_YesNoUnknown_CDC
Another
infection or colonization
MDRO
with another MDRO?
Co-infection
If patient has infection or
TBD
Type
colonization with another
MDRO, indicate the MDRO.
Date Arrived at Start date of visit/admission
N/A
Healthcare
Facility
Date Departed
End date of visit/admission
N/A
Healthcare
Facility

Carbon Monoxide
Poisoning
The impetus/urgency for
CDC to add data elements
for this condition

Data Element Name
Surveillance Data
Source

2

•

2

2

2

2

2

2

To make surveillance more comprehensive and informative for
public health actions including public health policy
• Enhanced surveillance to learn about the effects of long-term
exposures to low levels of CO, and monitor trends identify high
risk groups
• Additional data would help to better target outreach activities to
those at increased risk for CO poisoning
Value Set Code
CDC
Priority2
Data Element Description
Type of facility or provider
PHVS_DataReportingSource_CO 2
associated with the source of
information sent to Public
Health

R=Required; 1=Priority 1, 2=Priority 2, 3=Priority 3

4

Hepatitis
The impetus/urgency for
CDC to add data elements
for this condition

•

•

Data Element
Name
Laboratory Test
Ordering
Facility Type

The data element included in this request will contribute to
enhanced surveillance efforts for those jurisdictions funded
through PS21-2103 “Integrated Viral Hepatitis Surveillance and
Prevention Funding for Health Departments”.
The data element will improve standardization of data collection
for CDC surveillance and improve the overall understanding of the
population and factors contributing to viral hepatitis infection. The
enhanced surveillance will be more comprehensive and
informative for public health actions and will improve guidance on
infection control and prevention.
Value Set Code

Data Element Description
Type of facility where the
hepatitis laboratory
screening, diagnostic, or
monitoring test was ordered.

Leptospirosis
The impetus/urgency for
CDC to add data elements
for this condition

•
•
•
•

PHVS_SourceofLaboratoryTest
_Hepatitis

To make surveillance more comprehensive and informative for
public health actions related to travel
To provide more information about risk factors associated with
traveling
To harmonize collection of travel-related information amongst
Message Mapping Guides (MMGs) and facilitate future
jurisdiction implementation
To help monitor epidemiology
Value Set Code

Data Element Name
Travel Outside USA
Prior to Illness Onset
within Program Specific
Timeframe
Did the Case Travel
Domestically Prior to
Illness Onset
Specify Different Travel
Exposure Window

3

CDC
Priority1
2

Data Element Description
Did the subject travel
internationally in the six
months prior to illness onset?
Did the subject travel
domestically in the six
months prior to illness
onset?

PHVS_YesNoUnknown_CDC

CDC
Priority3
2

2
PHVS_YesNoUnknown_CDC

If the travel exposure
window used by the
jurisdiction is different from
that stated in the travel
exposure questions, specify

R=Required; 1=Priority 1, 2=Priority 2, 3=Priority 3

5

N/A

3

International
Destination(s) of Recent
Travel

the time interval in days
here. Otherwise, leave blank.
International destination or
countries the subject
traveled to

Travel State

Domestic destination,
state(s) traveled to
Date of Arrival to Travel Date of Arrival to Travel
Destination
Destination
Date of Departure from
Date of Departure from
Travel Destination
Travel Destination
Melioidosis
The impetus/urgency for
CDC to add data elements
for this condition

•
•
•
•

PHVS_Country_ISO_3166-1

2

PHVS_State_FIPS_5-2

2

N/A

3

N/A

3

To make surveillance more comprehensive and informative for public
health actions
To account for recent changes in case definition and identification in
the environment in the United States for the first time
To provide more information about risk factors (travel, environmental
exposures, underlying conditions) that have been associated with
infection
To monitor epidemiology and changes in disease patterns over time for
this emerging infection
Value Set Code

Data Element Name
Physician Name

Physician Phone
Patient Case Status
Microorganism Identified
in Isolate
Underlying Condition(s)
Immunocompromised
Associated Condition or
Treatment

Continents Visited

Most recent year visited

Data Element Description
Name of the physician or
clinician who diagnosed
and/or treated the patient
Phone number of the patient's
clinician/provider of care
Indicate the patient's case
status
Pathogen/Organism Identified
in Isolate
Listing of underlying causes
or prior illnesses
If the subject was
immunocompromised, what
was the associated
immunocompromising
condition or treatment?
Select all continents where
patient has visited or lived in
their lifetime
Most recent year visited
(continents)
6

N/A

CDC
Priority1
3

N/A

3

TBD

2

TBD

1

TBD

2

TBD

3

TBD

2

N/A

3

Visited or Lived in States

Travel

Travel Outside USA Prior
to Illness Onset within
Program Specific
Timeframe
Activity Type

Severe Weather Location

Event Notes
Signs and Symptoms
Indicator
Treatment Drug Indicator

Reason Medication Not
Completed
Antimicrobials Not Taken
or Discontinued
Disease Outcome Type
Specimen Source Site

Specimen Sent to CDC

Has the patient EVER visited
or lived in any of the
following US states in their
lifetime?
In the 30 days prior to illness
onset, did the patient travel 50
miles or more from their
normal residence?
Did the subject travel
internationally in the 30 days
prior to illness onset?

TBD

What activities led to the
indicated environmental or
animal exposure(s)?
Specify the location where
severe weather occurred (e.g.,
home, work)
Notes related to event
exposure
Indicator for associated signs
and symptoms
Did the subject receive
antimicrobials for this illness
or following an exposure?
Reason full course of
antimicrobials was not
completed
Did the patient complete the
course of antimicrobials
received?
Patient's status or outcome for
this condition
If specimen type is tissue,
indicate the anatomical source
(e.g., lung, kidney)
Was specimen(s) sent to CDC
for testing?

TBD

2

TBD

3

N/A

3

7

2

PHVS_YesNoUnknown_CDC 1

PHVS_YesNoUnknown_CDC 1

PHVS_YesNoUnknown_CDC 1
PHVS_YesNoUnknown_CDC 2

PHVS_ReasonMedication
NotCompleted_BSP

3

TBD

3

TBD

1

TBD

2

PHVS_YesNoUnknown_CDC 3

Viral Hemorrhagic
Fevers
The impetus/urgency for
CDC to add data elements
for this condition

Data Element Name
VSPB Epi-Number
DGMQ ID
Physician Name
Physician Email
Physician Phone
How was the case
identified
How was the case
identified, other
Detailed Ethnic Group
Resident of the United
States
Non-US city of residence
Non-US district of
residence
Signs and Symptoms
Signs and Symptoms
Indicator
Temperature Units
Signs and Symptoms
Onset Date

With 10 outbreaks of Ebola disease over the last five years, the risk of
introduction of the ebolavirus, the group of viruses that cause Ebola
disease, into the United States has resulted in the need for national
notifiable disease surveillance to assist in understanding the
transmission and epidemiology of the disease in U.S. jurisdictions. Due
to the most recent outbreak of Sudan virus disease, a disease caused by
Sudan virus (species Sudan ebolavirus), in Uganda, public health
agencies are monitoring ill travelers returning from Uganda for signs
and symptoms compatible with Ebola disease. In the event a case of
Ebola disease is detected in the United States, nationwide disease
surveillance is necessary to provide consistent case identification and
classification, measure the potential burden of illness, characterize the
epidemiology of medically attended Ebola disease in the United States,
detect community transmission, and inform public health response to
clusters of illness and efficacy of population-based non-pharmaceutical
interventions on the outbreak.
Value Set Code
CDC
1
Priority
Data Element Description
VSPB Epi-Number
N/A
1
DGMQ ID
N/A
2
Physician name
N/A
3
Physician email
N/A
3
Physician phone
N/A
3
How was the case identified?
TBD
3
How was the case identified,
TBD
3
other?
Other ethnicity
TBD
3
Is the patient a resident of the
PHVS_YesNoUnknown_CDC
2
United States?
Non-US city of residence
N/A
2
Non-US district of residence
N/A
2
Signs and symptoms associated TBD
3
with the illness being reported
Indicator for associated sign
PHVS_YesNoUnknown_CDC
2
and symptom
Celsius or Fahrenheit?
TBD
2
Signs and Symptoms Onset
N/A
2
date
8

Signs and Symptoms
Onset Date Unknown
Other Signs and
Symptoms, Specify
Other Signs and Symptoms
Onset Date
Other Signs and Symptoms
Onset Date Unknown
Additional Sign or
Symptom
Pregnancy Length

Signs and Symptoms Onset
Date, Unknown
Other symptom, specify

N/A

Other symptom onset date

N/A

Other symptom onset date,
unknown
Do you have another symptom
to enter?
Pregnancy length

N/A

Pregnancy Length
Indicator
Breastfeeding

Pregnancy length - weeks or
months
Breastfeeding

TBD

Malaria Test Performed

PHVS_YesNoUnknown_CDC

Malaria Test Type

Has malaria testing been
performed?
Type of malaria test

Other Malaria Test Type

Other type of malaria test

N/A

Malaria Test Result

Malaria test result

TBD

Malaria species associated
with previous illness
Location of Death, City

Malaria species

TBD

Location of death, city

N/A

Location of Death, State

Location of death, state

PHVS_State_FIPS_5-2

Was An Autopsy
Performed
Date of Autopsy

Was an autopsy or other
medical examination
performed on the body?
Autopsy date

Disposition of Body

Final disposition of the body

TBD

Cremation Date

Cremation date

N/A

Cremation Date Unknown

Cremation date unknown

N/A

Burial Date

Burial date

N/A

Burial Date Unknown

Burial date unknown

N/A

Hospital Name

Hospitalization facility name

N/A

2
2

City of Treatment Hospital

Hospitalization facility city

N/A

2

State of Treatment
Hospital
Patient Transport

Hospitalization facility state

PHVS_State_FIPS_5-2

2

How was the patient
transported?

TBD

2

2
N/A
2
2
2
PHVS_YesNoUnknown_CDC
N/A

2
2
2

PHVS_YesNoUnknown_CDC

TBD

2
2
2
2
2
2

9

1
1

PHVS_YesNoUnknown_CDC
2
N/A

2
2
2
2
2

Isolation Date

How was the patient
N/A
transported, other?
Was the patient managed under
PHVS_YesNoUnknown_CDC
isolation precautions?
Isolation date
N/A

Isolation Type

Isolation precaution types

TBD

1

Isolation Type Other

Other isolation precaution

N/A

1

Travel to Ebola-affected
Country/Region

Travel Country

Did the patient travel to an
Ebola-affected country/region
in the 3 weeks before
becoming ill?
Travel country

Travel City

Patient Transport Other
Isolation Precautions

2
1
1

1
PHVS_YesNoUnknown_CDC
PHVS_Country_ISO_3166-1

1

Travel city

N/A

1

Travel District/County

Travel district/county

N/A

1

Date of Arrival to Travel
Destination
Date of Departure from
Travel Destination
Reason(s) for Travel

Travel start date

N/A

1

Travel end date

N/A

1

Nature of travel

N/A

2

Travel for Medical/Relief
Organization
Reason for Travel Other

Medical/relief organization

TBD

2

Other nature of travel reason

N/A

2

Contact with Ebola Case

Has the patient had contact
with a symptomatic Ebola case
(suspect or confirmed), or
Ebola survivor in the 3 weeks
before becoming ill?
Contact with EVD case start
date
Contact with EVD end date

Contact with Ebola Case
Start Date
Contact with Ebola Case
End Date
Ebola Contact Type
Other Ebola Contact Type
Provide Care for Ebola
Patient

Provide Care for Ebola
Patient Start Date

Nature of contact with EVD
case
Other type of contact with
EVD case
Did the patient care for
someone who was sick or died
while in an Ebola-affected
country/region in the 3 weeks
before becoming ill?
Care for sick person start date

1
PHVS_YesNoUnknown_CDC

N/A

1

N/A

1

N/A

2

N/A

2
1

PHVS_YesNoUnknown_CDC

1
N/A

10

Provide Care for Ebola
Patient End Date
Contact Type
Other Contact Type
Visit Healthcare Facility

Healthcare Facility Name

1

Care for sick person end date
N/A
Nature of contact with ill
person
Other type of contact with ill
person
Did the patient visit a
healthcare facility or traditional
healer (witch doctor) while in
an Ebola-affected
country/region in the three
weeks before becoming ill?
Healthcare facility name

2
TBD
N/A

2
1

PHVS_YesNoUnknown_CDC

N/A

2

Country of Healthcare
Facility Outside the US
City of Healthcare Facility

Healthcare facility country

PHVS_Country_ISO_3166-1

1

Healthcare facility city

N/A

2

District/County of
Healthcare Facility
Date Arrived at Healthcare
Facility
Date Departed Healthcare
Facility
Healthcare Facility Reason
Visited
Healthcare Facility Reason
Visited Other
Enter Another Healthcare
Facility
Attend Funeral in Ebolaaffect Country/Region

N/A

2

N/A

2

N/A

2

TBD

2

N/A

2

Funeral Location Country

Healthcare facility
district/county
Healthcare facility admission
date
Healthcare facility discharge
date
Healthcare facility reason for
visit
Healthcare facility other reason
for visit
Do you want to enter another
facility?
Did the patient attend a funeral
in an Ebola-affected
country/region in the 3 weeks
before becoming ill?
Funeral location country

PHVS_Country_ISO_3166-1

1

Funeral Location City

Funeral location city

N/A

2

Funeral Location District

Funeral location district

N/A

2

Funeral Start Date

Start date of funeral

N/A

2

Funeral End Date

End date of funeral

N/A

2

Participate in Funeral
Practices

Did the patient participate in
burial practices (touch the
body, wash the body, wash
clothes of the deceased)?
Did the patient have any
animal contact in an Ebola-

Animal Contact Indicator

11

PHVS_YesNoUnknown_CDC

2
1

PHVS_YesNoUnknown_CDC

1
PHVS_YesNoUnknown_CDC
PHVS_YesNoUnknown_CDC

1

affected country/region in the 3
weeks before becoming ill?
Species of animal contact
TBD

1

Animal Contact Type
Other
Animal Contact Start Date

Other species of animal contact N/A

3

Start date of animal contact

N/A

2

Animal Contact End Date

End date of animal contact

N/A

2

Activity Type

Nature of animal contact

N/A

2

Animal Contact Type

Did the animal display any
symptoms of illness or was the
animal dead?
Consumed Meat from
Did the patient consume any
Ebola-affected
meat harvested from wild
Country/Region
animals in an Ebola-affected
country/region in the 3 weeks
before becoming ill?
Last Date of Wild Animal Last date of patient contacting
Meat Contact
meat harvested from wild
animals
Type of Wild Animal Meat Type of meat harvested from
wild animals
Other Type of Wild
Other type of meat harvested
Animal Meat
from wild animals
Time Spent in Mine/Cave
Did the patient work or spend
time in a mine/cave in an
Ebola-affected country/region
in the 3 weeks before
becoming ill?
Mine Location Country
Mine country

1

Sick Animal

PHVS_YesNoUnknown_CDC
1
PHVS_YesNoUnknown_CDC

N/A

2

TBD

1

N/A

3
1

PHVS_YesNoUnknown_CDC

PHVS_Country_ISO_3166-1

2

Mine Location
District/City
Last Date in Mine

Mine district/city

N/A

2

Last date in mine

N/A

2

Performing Laboratory
City
State of Facility

Performing Laboratory City

N/A

2

State of Facility

PHVS_State_FIPS_5-2

2

Performing Person Phone

Performing Person Phone

N/A

2

Laboratory Email

Laboratory Email

N/A

2

Non-CDC Laboratory
Type
Other Non-CDC
Laboratory Type

Non-CDC Laboratory Type

TBD

1

Other Non-CDC Laboratory
Type

N/A

1

12

Performing Laboratory
Location

Performing Laboratory
Location

13

N/A

1